NF-kappaB as a potential molecular target for cancer therapy. - Wikidata - awgldk - TriplyDB

NF-kappaB as a potential molecular target for cancer therapy.

NF-kappaB as a potential molecular target for cancer therapy.

http://www.wikidata.org/entity/Q36870474

about

The ubiquitin-like protein FAT10 mediates NF-kappaB activation New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer Inflammation in prostate cancer progression and therapeutic targeting UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer Transcription Factors in the Cellular Response to Charged Particle Exposure Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cells Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator Fibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosis Gadd45 proteins as critical signal transducers linking NF-kappaB to MAPK cascades Direct observation of a transient ternary complex during IκBα-mediated dissociation of NF-κB from DNA Therapeutic strategies for inhibiting invasion in glioblastoma.Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.Virtual screening against p50 NF-kappaB transcription factor for the identification of inhibitors of the NF-kappaB-DNA interaction and expression of NF-kappaB upregulated genes.Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitro.NF-κB gene signature predicts prostate cancer progression.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection.NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway.Icotinib inhibits the invasion of Tca8113 cells via downregulation of nuclear factor κB-mediated matrix metalloproteinase expression Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion.Hit identification of IKKβ natural product inhibitor.Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.Genomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation.Identifying novel glioma associated pathways based on systems biology level meta-analysis Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndrome Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation.CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis.Different patterns of NF-κB and Notch1 signaling contribute to tumor-induced lymphangiogenesis of esophageal squamous cell carcinoma Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.Design, synthesis and biological evaluation of bivalent benzoxazolone and benzothiazolone ligands as potential anti-inflammatory/analgesic agents.Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β.Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition.EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells

P2860

Q24328851-BC355960-0F1E-4DCE-9573-AED94EA10283 Q24619151-E43E66FE-324D-4414-BF83-82501D0C6FE2 Q26773610-E238E8BF-D7BB-4A61-91C3-8BBB5AF71A73 Q28069036-7474C763-437A-46AB-BE92-CC0A05C1332A Q28069717-5BE73062-246A-44C2-8AB2-6594D4F860D9 Q28257239-CC8D16F1-00BF-427D-8B79-75D9B68A840F Q28270149-426B4294-478F-4FA3-BBB9-91A02326C525 Q28297490-1D739BF9-D671-4FD2-902E-93C489C03B02 Q28386593-D1797B74-18BA-446D-85C0-C3016462774C Q28386926-F4CAC267-0FF6-49EE-8335-2C02E7BFCD89 Q28388105-208D38D4-35A0-4A34-A525-7ABBECB45C31 Q33357416-C03B568C-56DF-454A-998A-A8C7609F939E Q33426563-E368971A-0827-432F-B49F-6053444DBF98 Q33450973-C82244DC-73C1-4257-AAE2-9022824D8812 Q33508859-C59D47D2-9B2C-4AFB-89BE-20B944A3DC47 Q33598509-B115FF13-1FAF-4252-9928-94D010744555 Q33624908-A22EC2AA-CFA7-4AFE-ABEF-75080656FA68 Q33750977-01C6F69A-DADD-47F8-865E-D668ECC0EB1A Q33795121-C29BB4B5-3C4F-44FB-B1BA-DD83E0993390 Q33888327-04C562BF-BAC2-4E98-8B15-58A1449B7D6C Q33913958-54F2935F-F0A8-4109-81B1-4FADD5EA6C42 Q33967782-EFF9F9B0-D720-4225-9809-CFFE9FBBA1D1 Q34036019-19E7E62F-98E5-42BA-AF65-3F645ADF3190 Q34538026-68DB4648-383F-486B-9314-093E74087B71 Q34664057-83FB9592-905D-4B37-9ED8-44A098BB573D Q35058278-F6A970A9-460C-4223-AB97-4C5944DB281C Q35065451-783A9B56-17F4-4443-B433-3A7CBBED58E8 Q35102142-BABBAC23-F33D-4C0B-A288-B4C964FD41CF Q35169695-4E726DFF-FDD6-4675-A5D8-A9BE830492D3 Q35252803-4E5C7934-762C-4741-A6A7-FAD154D09D09 Q35541785-1E37DDBE-1B88-4A63-ABC8-51F0C72D5438 Q35549652-6BB8FF78-0F28-40F6-887A-10B04871B1FE Q35582297-C8F817AF-BC38-4FE5-81E9-0D5EF18FE61F Q35742808-74DCBA99-D272-4595-9042-0238ED6FE027 Q35803001-87809A7F-CD41-4628-A921-2C78CD6E7BB9 Q35806374-720D0961-9E0E-4FD4-934E-D402DC94E81F Q36370851-53EEE828-56AC-46F2-8A4B-6E0FE8C2BF9E Q36504317-67039B92-9C8C-4ED4-8B62-30D54BB9B33A Q36510801-04A3F962-0A28-4EC2-95F7-2D8E8D8D4399 Q36538277-084BF994-3FA7-40B3-B24A-89563B0D375B

P2860

NF-kappaB as a potential molecular target for cancer therapy.

http://www.wikidata.org/entity/Q36870474

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

NF-kappaB as a potential molecular target for cancer therapy.

@en

type

label

NF-kappaB as a potential molecular target for cancer therapy.

@en

prefLabel

NF-kappaB as a potential molecular target for cancer therapy.

@en

P1433

Q36870474-24CE57EF-CA3B-4A5E-9FD9-DB656BF9C48A

P1476

Q36870474-82930731-DAC9-4160-BB6B-352918C8220B

P2093

Q36870474-01841994-F87C-4D6E-9E89-349D257926A8

Q36870474-B21E36FA-5E67-4E57-8A75-E1D01D53870D

Q36870474-E12F999B-3F00-4591-8095-2DE524213EA5

Q36870474-F8F4385E-0156-4BF0-8139-6D5EF2B1AFAC

P2860

Q36870474-14B60E65-4356-43D9-ADBB-D09F1BCC9FE4

Q36870474-34F9E9F2-641C-4C4B-A358-BAED2189BD6E

Q36870474-7B694FAF-BB9F-4ABD-B516-110A3D5020FE

Q36870474-9FFE1E8F-B9A0-47B3-A912-B1B84C553E76

Q36870474-CE0BE04A-6382-4737-BAB2-382819DE89CF

Q36870474-E6D57684-D486-4D50-96CA-FE3943BCE512

Q36870474-E8769B4A-8EAD-46A3-B4DF-E0F8955B79C3

P304

Q36870474-F59DA00D-07EA-404D-B9F3-6C689D40124F

P31

Q36870474-5917CAE6-AAFF-46F5-B967-9226E971487B

P356

Q36870474-EFC59078-D741-48A1-BFA4-F0DBCE3852DF

P433

Q36870474-31372BE6-D591-4115-A8FC-5EADABFE6603

P478

Q36870474-FA167D09-2518-4F87-A8C4-5CD93189632B

P577

Q36870474-DE1CE418-FB1C-4F74-A4AF-E4CD387D50E5

P698

Q36870474-D6C62747-02FE-4D78-91FA-E580D5F7CFE8

P921

Q36870474-92C05B0E-2C2B-4DD4-9784-54E88B5B16A7

P356

BIOF.5520290103

P1433

P1476

NF-kappaB as a potential molecular target for cancer therapy.

@en

P2093

Chae Hyeong Lee

http://www.w3.org/2001/XMLSchema#string

Su-Hyeong Kim

http://www.w3.org/2001/XMLSchema#string

Yong-Sang Song

http://www.w3.org/2001/XMLSchema#string

Yong-Tark Jeon

http://www.w3.org/2001/XMLSchema#string

P2860

Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors

Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required

Function and activation of NF-kappa B in the immune system

Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors

Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability

Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.

P304

19-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BIOF.5520290103

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17611291

http://www.w3.org/2001/XMLSchema#string

P921